Birth Outcomes in Children Fathered by Men Treated with Anti-TNF-α Agents Before Conception
- 1 November 2016
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 111 (11) , 1608-1613
Abstract
Objectives: Methods: Results: Conclusions:Keywords
This publication has 31 references indexed in Scilit:
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ RegistryAmerican Journal of Gastroenterology, 2012
- Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathersScandinavian Journal of Rheumatology, 2012
- Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapyInflammatory Bowel Diseases, 2011
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The Danish Civil Registration SystemScandinavian Journal of Public Health, 2011
- High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancyAlimentary Pharmacology & Therapeutics, 2011
- Fertility and Reproduction in Male Patients with Ankylosing Spondylitis Treated with Infliximab: Table 1.The Journal of Rheumatology, 2009
- Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro modelFertility and Sterility, 2005
- Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid ArthritisAmerican Journal of Gastroenterology, 2004
- Pricing and reimbursement of drugs in DenmarkThe European Journal of Health Economics, 2003